Evaluation of Encephaloduroarteriosynangiosis Efficacy Using Probabilistic Independent Component Analysis Applied to Dynamic Susceptibility Contrast Perfusion MRI

References

1. 1.↵
   2. Adelson PD,
   3. Scott RM

   . Pial synangiosis for Moyamoya syndrome in children. Pediatr Neurosurg 1995;23;26–33 pmid:7495663

   PubMedWeb of Science
2. 2.↵
   2. Matsushima T,
   3. Inoue T,
   4. Ikezaki K, et al

   . Multiple combined indirect procedure for the surgical treatment of children with Moyamoya disease: a comparison with single indirect anastomosis and direct anastomosis. Neurosurg Focus 1998;5;e4 pmid:17112207

   PubMed
3. 3.↵
   2. Sainte-Rose C,
   3. Oliveira R,
   4. Puget S, et al

   . Multiple bur hole surgery for the treatment of Moyamoya disease in children. J Neurosurg 2006;105(6 suppl):437–43 pmid:17184074

   PubMedWeb of Science
4. 4.↵
   2. Scott RM,
   3. Smith JL,
   4. Robertson RL, et al

   . Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100(2 suppl pediatrics):142–49 pmid:14758941

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Dusick JR,
   3. Gonzalez NR,
   4. Martin NA

   . Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 2011;68:34–43; discussion 43 doi:10.1227/NEU.0b013e3181fc5ec2 pmid:21150753

   CrossRefPubMed
6. 6.↵
   2. Dusick JR,
   3. Liebeskind DS,
   4. Saver JL, et al

   . Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg 2012;117:94–102 doi:10.3171/2012.4.JNS111103 pmid:22559848

   CrossRefPubMed
7. 7.↵
   2. Gonzalez NR,
   3. Liebeskind DS,
   4. Dusick JR, et al

   . Intracranial arterial stenoses: current viewpoints, novel approaches, and surgical perspectives. Neurosurg Rev 2013;36:175–84; discussion 184–85 doi:10.1007/s10143-012-0432-z pmid:23097149

   CrossRefPubMed
8. 8.↵
   2. Starke RM,
   3. Komotar RJ,
   4. Connolly ES

   . Optimal surgical treatment for Moyamoya disease in adults: direct versus indirect bypass. Neurosurg Focus 2009;26:E8 doi:10.3171/2009.01.FOCUS08309 pmid:19335134

   CrossRefPubMed
9. 9.↵
   2. Gonzalez NR,
   3. Dusick JR,
   4. Connolly M, et al

   . Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations. J Neurosurg 2015;123:654–61 doi:10.3171/2014.10.JNS141426 pmid:26067617

   CrossRefPubMed
10. 10.↵
    2. Chimowitz MI,
    3. Lynn MJ,
    4. Derdeyn CP, et al

    ; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003 doi:10.1056/NEJMoa1105335 pmid:21899409

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Derdeyn CP,
    3. Chimowitz MI,
    4. Lynn MJ, et al

    ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet 2014;383:333–41 doi:10.1016/S0140-6736(13)62038-3 pmid:24168957

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Ginat DT,
    3. Smith ER,
    4. Robertson RL, et al

    . Imaging after direct and indirect extracranial-intracranial bypass surgery. AJR Am J Roentgenol 2013;201:W124–32 doi:10.2214/AJR.12.9517 pmid:23789684

    CrossRefPubMed
13. 13.↵
    2. Blauwblomme T,
    3. Lemaitre H,
    4. Naggara O, et al

    . Cerebral blood flow improvement after indirect revascularization for pediatric Moyamoya disease: a statistical analysis of arterial spin-labeling MRI. AJNR Am J Neuroradiol 2016;37:706–12 doi:10.3174/ajnr.A4592 pmid:26585258

    Abstract/FREE Full Text
14. 14.↵
    2. Yoon HK,
    3. Shin HJ,
    4. Lee M, et al

    . MR angiography of moyamoya disease before and after encephaloduroarteriosynangiosis. AJR Am J Roentgenol 2000;174:195–200 doi:10.2214/ajr.174.1.1740195 pmid:10628478

    CrossRefPubMed
15. 15.↵
    2. Robertson RL,
    3. Burrows PE,
    4. Barnes PD, et al

    . Angiographic changes after pial synangiosis in childhood moyamoya disease. AJNR Am J Neuroradiol 1997;18:837–45 pmid:9159360

    Abstract/FREE Full Text
16. 16.↵
    2. Lee SK,
    3. Kim DI,
    4. Jeong EK, et al

    . Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol 2003;24:741–47 pmid:12695215

    Abstract/FREE Full Text
17. 17.↵
    2. Liebeskind DS,
    3. Sanossian N

    . How well do blood flow imaging and collaterals on angiography predict brain at risk? Neurology 2012;79:S105–09 doi:10.1212/WNL.0b013e3182695904 pmid:23008383

    CrossRefPubMed
18. 18.↵
    2. Sam K,
    3. Poublanc J,
    4. Sobczyk O, et al

    . Assessing the effect of unilateral cerebral revascularization on the vascular reactivity of the non-intervened hemisphere: a retrospective observational study. BMJ Open 2015;5:e006014 doi:10.1136/bmjopen-2014-006014 pmid:25673438

    Abstract/FREE Full Text
19. 19.↵
    2. Oh SW,
    3. Kim YK,
    4. Kim SK, et al

    . Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT. Ann Nucl Med 2012;26:47–57 doi:10.1007/s12149-011-0541-8 pmid:22033781

    CrossRefPubMed
20. 20.↵
    2. Dai DW,
    3. Zhao WY,
    4. Zhang YW, et al

    . Role of CT perfusion imaging in evaluating the effects of multiple burr hole surgery on adult ischemic Moyamoya disease. Neuroradiology 2013;55:1431–38 doi:10.1007/s00234-013-1291-1 pmid:24153446

    CrossRefPubMed
21. 21.↵
    2. Lu CF,
    3. Chou YC,
    4. Guo WY, et al

    . Brain MR perfusion image segmentation using independent component analysis and hierarchical clustering. Conf Proc IEEE Eng Med Biol Soc 2007;2007:5547–50 pmid:18003269

    PubMed
22. 22.↵
    2. LaViolette PS,
    3. Cohen AD,
    4. Prah MA, et al

    . Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma. Neuro Oncol 2013;15:442–50 doi:10.1093/neuonc/nos323 pmid:23382287

    Abstract/FREE Full Text
23. 23.↵
    2. Damoiseaux JS,
    3. Rombouts SA,
    4. Barkhof F, et al

    . Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A 2006;103:13848–53 doi:10.1073/pnas.0601417103 pmid:23382287

    Abstract/FREE Full Text
24. 24.↵
    2. Calhoun VD,
    3. Liu J,
    4. Adali T

    . A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data. Neuroimage 2009;45:S163–72 doi:10.1016/j.neuroimage.2008.10.057 pmid:19059344

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Onton J,
    3. Westerfield M,
    4. Townsend J, et al

    . Imaging human EEG dynamics using independent component analysis. Neurosci Biobehav Rev 2006;30:808–22 doi:10.1016/j.neubiorev.2006.06.007 pmid:16904745

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Delorme A,
    3. Makeig S

    . EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 2004;134:9–21 doi:10.1016/j.jneumeth.2003.10.009 pmid:15102499

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Smith SM,
    3. Fox PT,
    4. Miller KL, et al

    . Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci U S A 2009;106:13040–45 doi:10.1073/pnas.0905267106 pmid:19620724

    Abstract/FREE Full Text
28. 28.↵
    2. Beckmann CF,
    3. Smith SM

    . Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 2004;23:137–52 doi:10.1109/TMI.2003.822821 pmid:14964560

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Nichols K,
    3. Holmes A

    . Non-parametric procedures. Statistical Parametric Mapping 2007;253–72 doi:10.1016/B978-012372560-8/50021-8

    CrossRef
30. 30.↵
    2. Macchi C,
    3. Catini C,
    4. Federico C, et al

    . Magnetic resonance angiographic evaluation of circulus arteriosus cerebri (circle of Willis): a morphologic study in 100 human healthy subjects. Ital J Anat Embryol 1996;101:115–23 pmid:8997907

    PubMed
31. 31.↵
    2. Lee SC,
    3. Jeon JS,
    4. Kim JE, et al

    . Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature. Acta Neurochir (Wien) 2014;156:103–11 doi:10.1007/s00701-013-1921-8 pmid:24201757

    CrossRefPubMed
32. 32.↵
    2. Amin-Hanjani S,
    3. Singh A,
    4. Rifai H, et al

    . Combined direct and indirect bypass for moyamoya: quantitative assessment of direct bypass flow over time. Neurosurgery 2013;73:962–67; discussion 967–68 doi:10.1227/NEU.0000000000000139 pmid:23949274

    CrossRefPubMed
33. 33.↵
    2. Ryu WS,
    3. Park SS,
    4. Kim YS, et al

    . Long-term natural history of intracranial arterial stenosis: an MRA follow-up study. Cerebrovasc Dis 2014;38:290–96 doi:10.1159/000367587 pmid:25412772

    CrossRefPubMed
34. 34.↵
    2. Kim YI,
    3. Phi JH,
    4. Paeng JC, et al

    . In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric Moyamoya disease. J Nucl Med 2014;55:1467–72 doi:10.2967/jnumed.114.142430 pmid:25060195

    Abstract/FREE Full Text
35. 35.↵
    2. Calamante F,
    3. Gadian DG,
    4. Connelly A

    . Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466–73 pmid:10975900

    CrossRefPubMed
36. 36.↵
    2. Wu O,
    3. Østergaard L,
    4. Weisskoff RM, et al

    . Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164–74 doi:10.1002/mrm.10522 pmid:12815691

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Kao YH,
    3. Teng MM,
    4. Liu KC, et al

    . Hemodynamic segmentation of MR perfusion images in patients with unilateral carotid stenosis using independent component analysis. J Magn Reson Imaging 2008;28:1125–32 doi:10.1002/jmri.21537 pmid:18972353

    CrossRefPubMed
38. 38.↵
    2. McKeown MJ,
    3. Makeig S,
    4. Brown GG, et al

    . Analysis of fMRI data by blind separation into independent spatial components. Hum. Brain Mapp 1998;6:160–88 pmid:9673671

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Kao YH,
    3. Guo WY,
    4. Wu YT, et al

    . Hemodynamic segmentation of MR brain perfusion images using independent component analysis, thresholding, and Bayesian estimation. Magn Reson Med 2003;49:885–94 doi:10.1002/mrm.10440 pmid:12704771

    CrossRefPubMedWeb of Science
40. 40.↵
    2. LaViolette PS,
    3. Daun MK,
    4. Paulson ES, et al

    . Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma. J Neurooncol 2014;16:543–49 doi:10.1007/s11060-013-1318-9 pmid:24293201

    CrossRefPubMed
41. 41.↵
    2. Ramalho J,
    3. Semelka RC,
    4. Ramalho M, et al

    . Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am J Neuroradiol 2016;37:1192–98 doi:10.3174/ajnr.A4615 pmid:26659341

    Abstract/FREE Full Text
42. 42.↵
    2. Stojanov D,
    3. Aracki-Trenkic A,
    4. Benedeto-Stojanov D

    . Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status. Neuroradiology 2016;58:433–441 doi:10.1007/s00234-016-1658-1 pmid:26873830

    CrossRefPubMed